相关实验视频
作为癌症化疗的点,多 (ADP-ribosylation) 是一种多 (ADP-ribosylation) 的药物
1Institute of Cancer Research, Sutton, UK.
Lancet (London, England)
|September 11, 1993
概括
No abstract available in PubMed .
1Institute of Cancer Research, Sutton, UK.
No abstract available in PubMed .